Quality, control and validation of glucometers and CGM systems. Status overview
Authors:
B. Friedecký 1,2; J. Kratochvíla 2; D. Springer 3
Authors‘ workplace:
Ústav klinické biochemie a diagnostiky Fakultní nemocnice Hradec Králové
1; SEKK s. r. o. Pardubice
2; Ústav lékařské biochemie a laboratorní diagnostiky 1. LF UK a VFN Praha
3
Published in:
Klin. Biochem. Metab., 24, 2016, No. 2, p. 75-81
Overview
The communication deals with current state of analytical quality for measuring the glucose in blood by glucometers and continuous glucose monitoring (CGM).Quality requirements for blood glucose measurement of ISO 15197 and FDA 2014 standards are described and results of recent studies of their evaluations in used glucometers are introduced. These results show very different level of quality in glucometers and high degree of lot-to-lot variation. Also, programs of external quality assessment provide similar picture on measurement quality. We describe current limited possibilities of control materials in quality assessment, namely in case of bias determination. Quality requirements based on recommendations of US FDA guidance is also part of this publication. We summarize the recent state of quality measurement of continuous glucose monitoring.
Keywords:
Glucometers, continuous monitoring of glucose, quality requirements, quality assessment.
Sources
1. Freckmann, G., Schmid, C., Baumstark, A., Rutschmann, M., Haug, C., Heinemann, L. Analytical performance requirements for self-monitoring of blood glucose with focus on system accuracy:relevant differences among ISO 15197:2003, ISO 15197:2013 and FDA recommendations. J. Diabet. Sci. Technol., 2015. DOI: 10.1177/1932296815580160.
2. Sacks, D. B., Bruns, D. E., Horton, J., Lindberg, S., Mahoney, J. J., Manzella, S. et al. Point-of- Care Glucose Testing in Acute and Chronic Care Facilities. Approved Guideline –Third Edition. CLSI 2013: POCT 12-A3. Dostupné na: http://shop.clsi.org/point-of-care-documents/POCT12.html.
3. Müller, P., Hattener, A., Stephen, P. Assessing system accuracy of blood glucose monitoring systems using rectangle target plots. J. Diabetes Sci. Technol., 2015, 1932296815612496, first published on October 9, 2015 as doi:10.1177/1932296815612496.
4. Freckmann, G., Link, M., Baumstark, A., Schmid, C., Pleus, S. et al. System accuracy evaluation of 10 SMBG systems with 3 lots each following ISO 15197:2013 against 2 different comparison methods. 50th EASD annual meeting Vienna 2014. Poster Nr.1017.
5. Freckmann, G., Schmid, C., Baumstark, A., Pleus, S., Link, M., Haug, C. System accuracy evaluation of 43 blood glucose according to DIN EN ISO 15197. J. Diabetes Sci. Technol., 2012, 6: p. 1060-1075.
6. Freckmann, G., Schmid, C., Pleus, S., Baumstark, A., Link, M. et al. System accuracy evaluation of systems for point-of-care testing of blood glucose: a comparison of a patient-use system with six professional-use systems. Clin. Chem. Lab. Med., 2014, 52/7: p. 1079-1086.
7. Brazg, R., Klaff, L. J., Parkin, C. G. Performance variability of seven commonly used self-monitoring of blood glucose systems: clinical considerations for patients and provider. J. Diabetes Sci. Technol., 2013, 7/1: p. 144-152.
8. Hofmans, M., Oyaert, M., De Schriver, P., Nobels, F., Van Hoovels, L. Clinical laboratories have a critical role in test strips lot management in glucose point-of-care testing. Clin. Chem. Lab. Med. DOI 10.1515/cclm-2015-0820.
9. Selvik, U. O., Risa, M., Jacobsen, C. E., Monsen, G., Sandberg, S. Performance of 10 systems for self-monitoring of blood glucose by trained healthcare professionals and in the hands of the users. Clin. Chem., 2015, 61/5: p. 772-774.
10. Springer, D., Omastová, K., Zima, T. Nástrahy testování POCT systémů pro stanovení glukózy. Klin. Biochem. Metab., 2015, 3: p. 145. Celostátní sjezd klinické biochemie Brno 2015. Poster P-9.
11. Friedecký, B., Kratochvíla, J. SKUP – cesta ke zvýšení kvality péče o pacienty. Prakt. Lék., 2012, 10: p. 492-494.
12. Schumann, G. POCT for glucose measurements in different matrix-reference systems can provide solutions for improved analytical quality. Labquality Days 2016 Helsinki. Dostupné na: http://www.labquality.fi/labquality-paivat/in-english/labquality-days-2016/program/.
13. US Food and Drug Administration: Self-momitoring Blood Glucose Test Systems for Over-the-Counter Use. Draft Guidance for Industry and Food and Drug Administration Staff. 2014. UCM 380327.pdf. Dostupné na: http://www.fda.gov.
14. Bailey, T. S., Grunberger, G., Bode, B. W., Handelmann, Y., Hirsch, I. B., Jovanovič, L. et al. American Association of Clinical Endocrinologists and American College of Endocrinology 2016. Outpatient glucose monitoring consensus statement. Endocrinology Practice, 2016, 22/2: p. 231-261.
15. Ji, L. N., Guo, L. X., Liu, L. B. Accuracy and Presision Assessment of a New Blood Glucose Monitoring System. Clin. Chem. Lab. Med., 2016, 54: p. 181-188.
16. Wilinska, M. E., Hovorka, R. Glucose control in the intensive care unit by use of continuous glucose monitoring: what level of measurement error is acceptable? Clin. Chem., 2014, 60: p. 1500-1509.
17. Kirchsteiger, H., Heinemann, L., Freckmann, G., Lodwig, V., Schmelzeisen-Redeker, G. et al. Performance comparison of CGM systems: MARD values are not always a reliable indicator of CGM system accuracy. J. Diabetes Sci. Technol., 2015, 9: p. 1030-1040.
18. Andelin, M., Kropff, J., Matuleviciene, V., Joseph, J. I., Attwall, S., Theodorsson, E. et al. Assessing the accuracy of continuous glucose monitoring (CGM) calibrated with capillary values using capillary or venous glucose levels as a reference. J. Diabetes Sci. Technol., 2016 pii:1932296815626724.
19. Matuleviciene, V., Joseph, J. I., Andelin, M., Kirsch, I. B., Attwall, S., Pivodic, A. et al. A clinical trial of the accuracy and treatment experience of the Dexcon G4 sensor and Enlite Sensor (guardian real time system) tested simultaneously in ambulantory patients with type I diabetes. Diabetes Technol. Ther., 2014, 16: p. 759-767.
20. Damiano, E. R., McKeon, K., El-Khabib, F. H., Zheng, H., Nathan, D. M., Russel, S. J. et al. A comparative effectiveness analysis of three continuous glucose monitors:The Navigator,G4 Platinum and Enlite. J. Diabetes Sci. Technol., 2014, 8: p. 699-708.
21. Garcia, A., Rack-Gomer, A. L., Bhavaraju, N. C., Haripriyan, H., Kanath, A., Peyser, T. et al. Dexcon G4AP an advanced continuous glucose monitor for the artificial pancreas. J. Diabetes Sci. Technol., 2013, 7: p. 1436-1445.
22. Laffel, L. Improved accuracy of continuous glucose monitoring systems in pediatric patients with diabetes mellitus:results from two studies. Diabetes Technol. Ther., 2016 Suppl.2 S223-S233 DOI:10.1089/dia.2015.0380.
23. Peyser, T., Nakamura, K., Price, D., Bonnett, L. C., Hirsch, I. B., Bato, A. et al. Hypoglycemic accuracy and improved low glucose alerts of the latest Dexcom G4 Platinum continuous monitoring systém. Diabetes Technol. Ther., 2015, 17: p. 548-554.
24. Vetoretti, M., Facchinetti, A., Del Favero, S., Sparacino, G., Cotelli, C. On-line calibration of glucose sensors from the measured current by a time-varying calibration function and Bayesian priors. IEEE Trans. Biomed. Eng., 2015 E pub
25. Bailey, T., Bode, B. W., Christiansen, H. P., Klaff, L. J., Alva, S. The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System. Diabetes Technol. Ther., 2015, 17: p. 787-794.
26. Rodbard, D. Continuos glucose monitoring: A review of successes, challenges and opportunities. Diabetes Technol. Ther., 2016, 18, Suppl.2: S2 3-13.
27. Bailey, T., Wallace, J. F., Greene, C., Pardo, S., Brown, D., Pflug, D. I., Klaff, L. J. Accuracy and user performance evaluation of the Contour Next Link 2.4.blood glucose monitoring system. Clin. Chim. Acta, 2015, 448, 25: p. 135-146.
28. POCT 12 A3. Point-Of-Care Blood Glucose Testing in Acute and Chronic Care Facilities. Approved Guideline-Third Edition. Clinical Laboratory Standard Institute 2013.
29. ČSN EN ISO 15197:2004. Systémy diagnostických zkoušek in vitro - Požadavky na systémy monitorování glykémie pro sebekontrolu pacientů s diabetes mellitus. UNMZ 2004.
30. ČSN EN ISO 15197:2013. Systémy diagnostických zkoušek in vitro - Požadavky na systémy monitorování glykémie pro sebetestování pacientů s diabetes mellitus. UNMZ 2016.
31. Materiál UZIS 2013, dostupné na webové adrese: http://www.uzis.cz
Labels
Clinical biochemistry Nuclear medicine Nutritive therapistArticle was published in
Clinical Biochemistry and Metabolism
2016 Issue 2
Most read in this issue
- Quality, control and validation of glucometers and CGM systems. Status overview
- Postanalytical phase and interpretation of laboratory tests
- Activity of phosphomannomutase 2 in patients with suspected congenital disorder of glycosylation
- Chips and Capillary Electrophoresis Based Immunoassays